NanoVibronix, Inc. announced it has signed a non-binding term sheet for a license and supply agreement with APOGEPHA Arzneimittel GmbH.
APOGEPHA Arzneimittel GmbH is a German pharmaceutical company specializing in the development, marketing, sales, and distribution of urology products. This partnership aims to expand the sales of UroShield in Germany.
This agreement represents a strategic move to enter and grow the market for UroShield within Germany. It leverages APOGEPHA's expertise and network in the urology sector to enhance product distribution and reach.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.